Statistics
Publications
31
Citations
6.8K
H-Index
28
Active since
1991
Gregory R. Hoffman is an author at Novartis (Switzerland) specializing in life sciences, molecular biology, and cell signaling.
Publications per year
1991–2021
31
31
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
Robert J. Ihry, Kathleen A. Worringer, Max R. Salick et al. · Nature Medicine · 2018 · 1K citations
DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks
Megan van Overbeek, Daniel Capurso, Matthew M. Carter et al. · Molecular Cell · 2016 · 503 citations · Full text
1–5 of 31